Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study

Kai-Hung ChengDivision of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; ;Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan;

http://orcid.org/0000-0003-1066-9499

Kai-Chun ChengDepartment of Ophthalmology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; ;Department of Ophthalmology, Kaohsiung Municipal Hsiao-kang Hospital, Kaohsiung, Taiwan; ;Department of Optometry, Shu-Zen Junior College of Medicine and Management, Kaohsiung, Taiwan

Kai-Yuan ChengDepartment of Otolaryngology, Head and Neck Surgery, Ministry of Health and Welfare Pingtung Hospital, Pingtung, Taiwan;

Yi-Hsin YangSchool of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan;

Chung-Wei LeeDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA; ;Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA;

Wen-Ter LaiDepartment of Internal Medicine, Kaohsiung Municipal United Hospital, Kaohsiung, Taiwan; Correspondence[email protected]

Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date